| Caption | CEO and cofounder of Standigm, Jinhan Kim, is introducing the new AI based drug discovery services, ‘Expander’ and ‘Hunter’ at the Bio-Europe 2017 in Berlin, Germany. Photo credit: Standigm |
| Source | Standigm |
| Download | |
| Related Press Releases Links |
Standigm, an AI based Drug Discovery Company, Launched AI Drug Discovery Services Publicly at Bio-Europe 2017 in Berlin, Germany AIベースの創薬企業Standigmがドイツ・ベルリンのBio-Europe 2017でAI創薬サービスを公式開始 AIベースの創薬企業Standigmがドイツ・ベルリンのBio-Europe 2017でAI創薬サービスを公式開始 |